See our other webinars
Agenda
- Presentation of the Barrett's Esophagus disease: Epidemilology, history of diagnosis and treatment - Dr. Rehan Haidry
- Indications for endoscopic eradication therapy in BE and patient selection - Prof. Raf Bisschops
- Barrx™ RFA, the standard of care therapy according to guidelines - Dr. David Graham
- Faculty discussion - Chaired by Dr. Roos Pouw
Chair
- Dr. Roos Pouw
Speakers
- Dr. Rehan Haidry
- Prof. Raf Bisschops
- Dr. David Graham
Speaker Biographies
Dr. Rehan Haidry
Rehan Haidry is a Consultant Gastroenterologist and Endoscopist at University College Hospital, London, one of the country’s leading teaching hospitals. He has expertise in general gastroenterology and hepatology.
He trained at St Mary’s Hospital, London and completed his gastroenterology training in North East London. He then undertook a prestigious 2-year research fellowship at UCLH, examining novel diagnostic and therapeutic endoscopic techniques in the upper gastrointestinal tract, including endoscopic treatment of early cancers. He has a particular interest in managing and treating patients with acid reflux symptoms and also Barrett’s Esophagus.
Dr. Haidry has ongoing clinical research commitments in the Division of Surgery & Interventional Science at UCL. His research interests are focused on the development of new methods for detecting and treating dysplasia (early cancer) in Barrett’s Esophagus and other pathologies of the gastrointestinal tract. He is involved in coordinating Europe’s largest patient registry, the UK HALO radiofrequency ablation registry which collects nationwide outcomes of this exciting new intervention in patients with early cancer of the esophagus.
Prof. Raf Bisschops
Raf
Bisschops obtained his medical degree in 1997, a PhD degree and certification in gastroenterology in 2005 at the University of Leuven. He is head of clinic and associate professor at the Catholic University of Leuven (KU Leuven), faculty of medicine. He is director of endoscopy since 2013. His main interest is advanced endoscopic imaging and therapeutics for premalignant conditions (Barrett, HNPCC, colitis), artificial intelligence and quality in endoscopy. He was co-editor of the journal Endoscopy between 2011 and 2020. He was the president of the Belgian Society of Gastrointestinal Endoscopy between 2019-2021. Within the European Society of Gastrointestinal Endoscopy, he is currently the Secretary General, and served as chairman of the ESGE quality committee and chairman of the ESGE curriculum working group.
Dr. David Graham
David Graham is a Consultant Gastroenterologist at University College Hospital, London. He trained at St Bartholomew’s and the Royal London Medical School and completed Gastroenterology training in North East London. He undertook a PhD at UCL focussing on the early detection of esophageal cancer through the utilisation of salivary “liquid biopsies” and artificial intelligence analysis of patient data.
He has a specialist interest in Barrett’s Esophagus, oesophago-gastric cancer, endoscopic imaging technologies and interventional endoscopy. Additionally, he was part of the expert committee devising the BSG guidelines for the management of the pre-malignant and early malignant lesions of the stomach and is part of international research collaborations aiming to improve the early detection of these lesions.
Finally, David has a keen interest in endoscopy training and has helped run many live endoscopy courses at UCH.
Dr. Roos Pouw
Roos Pouw is a gastroenterologist and principal investigator at the department of Gastroenterology & Hepatology at the Amsterdam University Medical Center, The Netherlands. In 2011 Roos obtained her PhD-degree Cum Laude with her thesis entitled "Endoscopic eradication of Barrett's Esophagus with early neoplasia." Next to her clinical work, Roos supervises a number of research lines on endoscopic management of early Barrett's neoplasia, and for this work she received the UEG Rising Star Award 2020. Furthermore, Roos is active as editorial (advisory) board member for the UEG Journal and Best Practice & Research: Clinical Gastroenterology.